Corporate News     22-Feb-20
AstraZeneca Pharma India launches QTERN® in India
AstraZeneca Pharma India has commenced the launch of QTERN® in India. The company has already received the Import and Market Permission in Form 45 (Marketing Authorization) from the Drugs Controller General of India for FDC of Dapagliflozin 10mg + Saxagliptin 5mg film coated tablets (QTERN®).

FDC of Dapagliflozin 10mg + Saxagliptin 5mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM).

Previous News
  Astrazeneca Pharma India standalone net profit rises 96.78% in the June 2022 quarter
 ( Results - Announcements 08-Aug-22   14:55 )
  Astrazeneca Pharma India fixes record date for final dividend
 ( Market Beat - Reports 26-Jun-24   09:51 )
  AstraZeneca Pharma, Mankind Pharma partner to accelerate access to asthma medicine
 ( Hot Pursuit - 12-Mar-24   13:02 )
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 10-Aug-21   10:00 )
  Astrazeneca Pharma India to convene board meeting
 ( Corporate News - 03-Nov-21   16:58 )
  Board of Astrazeneca Pharma India appoints director
 ( Corporate News - 15-Mar-19   13:04 )
  Astrazeneca Pharma India reports standalone net profit of Rs 8.67 crore in the December 2015 quarter
 ( Results - Announcements 06-Feb-16   16:31 )
  Astrazeneca Pharma India AGM scheduled
 ( Corporate News - 27-May-21   14:24 )
  Astrazeneca Pharma India reports standalone net profit of Rs 3.22 crore in the March 2018 quarter
 ( Results - Announcements 22-May-18   16:24 )
  Board of Astrazeneca Pharma India recommends interim dividend
 ( Corporate News - 09-Aug-21   20:10 )
  Astrazeneca Pharma India schedules AGM
 ( Corporate News - 17-Aug-18   12:56 )
Other Stories
  GRP schedules AGM
  01-Jul-24   20:01
  Mahindra & Mahindra domestic PV sales jump 23% in June
  01-Jul-24   20:01
  Vipul Organics constructs new factory in Ambernath, Maharashtra
  01-Jul-24   20:00
  Greaves Engineering launches range of new CPCB IV+ Compliant Gensets
  01-Jul-24   19:41
  Godrej Properties to develop 7-acre land in Thanisandra, North Bengaluru
  01-Jul-24   19:39
  Rama Phosphates AGM scheduled
  01-Jul-24   19:34
  Take Solutions to convene AGM
  01-Jul-24   19:34
  Fischer Medical Ventures partners with Singapore-based Nervotec
  01-Jul-24   19:29
  NIIT appoints Pankaj Jathar as Chief Executive Officer
  01-Jul-24   19:27
  Dynacons Systems recognized as India's Leading Listed ESG Entities 2024
  01-Jul-24   19:26
Back Top